Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
127M
-
Number of holders
-
144
-
Total 13F shares, excl. options
-
55.9M
-
Shares change
-
+1.01M
-
Total reported value, excl. options
-
$150M
-
Value change
-
+$2.05M
-
Put/Call ratio
-
0.39
-
Number of buys
-
74
-
Number of sells
-
-69
-
Price
-
$2.69
Significant Holders of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) as of Q4 2022
170 filings reported holding ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value as of Q4 2022.
Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) has 144 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.9M shares
of 127M outstanding shares and own 44.09% of the company stock.
Largest 10 shareholders include BlackRock Inc. (11.1M shares), Soleus Capital Management, L.P. (7.36M shares), VANGUARD GROUP INC (4.82M shares), FEDERATED HERMES, INC. (2.89M shares), STATE STREET CORP (2.48M shares), AQR CAPITAL MANAGEMENT LLC (2.19M shares), MORGAN STANLEY (1.98M shares), MILLENNIUM MANAGEMENT LLC (1.73M shares), GEODE CAPITAL MANAGEMENT, LLC (1.47M shares), and Assenagon Asset Management S.A. (1.44M shares).
This table shows the top 144 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.